Imatinib Inhibits EphB Abl Signaling Pathway and Suppresses Colorectal Cancer
Researchers from Karolinska Institutet in Sweden and Nanyang Technological University in Singapore showed that the drug Imatinib, a tyrosine kinase inhibitor ... Read more